Kymos Group

#ConnectionDay2026 is live at World Trade Center Barcelona! Our team is on site connecting with partners and exploring new collaborations across the catalan life sciences ecosystem. 📅 6 May 📍 Barcelona Come say hi! 👋

🆕 Validating cannabinoid bioanalysis isn’t straightforward. Measuring CBD, THC and their metabolites in plasma requires sensitivity, selectivity and robust methods. We present a 6-analyte LC-MS/MS approach with low LOQ in our latest article: 🔗 kymos.com/news/cannabino…

BIOKOREA 2026 is live in Seoul 🇰🇷 Cosme Aragonés and Yoonjin Kim are on site at COEX, connecting with partners across the global bio-health industry. 📅 28–30 April |📍 Seoul Come say hi! 👏

Kymos Group is attending the Cell & Gene Meeting on the Med in Rome this week 🇮🇹 Our BD for Italy & South Mediterranean, Alexandros Chatgilialoglu, will be there to connect and explore new collaborations. 📅 28–30 April | 📍 Rome Cavalieri Hotel 📩 alexandros@kymos.com

▶️ This Sunday, Kymos Group joined the Magic Line Sant Joan de Déu in Barcelona. ~50 colleagues walked 9 km together, supporting a shared cause. Thanks to everyone who made it happen. #MagicLineSJD #SantJoanDeDeu #KymosGroup #Volunteering

German Biotech Days is live in Leipzig! 🇩🇪 Judith Oettl is onsite connecting with partners and industry peers at the Kongresshalle. Looking forward to two great days of networking. Come say hi! 👋 #GermanBiotechDays #biotech

25 years of Kymos Group: the first lab in action. 🔬 After setting up our first laboratory at the Parc Científic de Barcelona, we began our first projects. These images, from our 2001 catalog, capture those early days. #Kymos25 #LifeSciences #CRO

▶ Meet Kymos Group at German Biotech Days in Leipzig! Our Business Director Germany, Judith Oettl, will be there to connect and explore new opportunities. Discover our CMC & bioanalytical services across #Biologics, #SmallMolecules, #TIDES & #AdvancedTherapies.

25 years of Kymos Group: the people behind the journey. Jaume Pascual, founding member and Quality Director, leads QA across all sites, ensuring work under GLP/GMP standards and reliable, trusted results. “Quality is not only about compliance; it’s about building trust.”

📚🔬 A few weeks ago, our team visited Institut La Romànica to meet a new group of students and share insights into life in a CRO. Always a pleasure to come back each year. Thank you for the warm welcome and great questions! 👏 #KymosGroup #STEM #FutureTalent

🆕 Our Business Director in Germany, Judith Oettl, shares her perspective in an interview with Wirtschaftsforum on the role of specialized laboratories in advancing modern drug development. 👉 Read the full interview (in German): wirtschaftsforum.de/news/fuer-die-…

🆕 One-stop solutions can simplify complex studies by aligning bioanalysis, study management, and operations. In our latest article, we explore how this approach supports bioequivalence, clinical, and preclinical programs. 🔗 kymos.com/news/one-stop-…

📊🔬 Kymos Group Marketing & Sales Summit 2026 This year, we gathered in Copenhagen to connect with our new colleagues, explore their lab and services, and align on integrating their capabilities across the group. Stronger together, ready to deliver more value to our clients.

📢 Kymos Group successfully completes an FDA Remote Regulatory Assessment at our Germany site with no observations. All our four sites are now FDA inspected, including our recently added one in Denmark. Read the full communication on LinkedIn 👇 linkedin.com/feed/update/ur…

📢 Kymos Group Annual Informative Session Last Friday, we reviewed 2025 achievements and shared our roadmap for 2026. A special edition marking our 25th anniversary and the acquisition of Particle Analytical. Looking ahead to another year of growth!

Only a subset of anti-drug antibodies actually block the drug–target interaction. These #NeutralizingAntibodies (NAb) can directly impact PK/PD, making their assessment a key step in immunogenicity testing. Learn more 👉kymos.com/news/neutraliz…

25 years of Kymos Group: building our first lab 🔬 Shortly after our founding in 2001, we began setting up our first laboratory at the Parc Científic de Barcelona. From those first instruments and benches, the Kymos journey began. #Kymos25 #LifeSciences #CRO

25 years of Kymos Group also means recognizing the people behind the journey. Our CEO Joan Puig de Dou, with 30+ years in the pharmaceutical industry, has been leading Kymos since 2015, supporting its growth and international expansion. #Kymos25 #LifeSciences #CRO

Our CEO Joan Puig de Dou and part of the Kymos Group management team visited our new site in Hørsholm to meet the Particle Analytical ApS team in person. Good conversations, new faces, and yes, cake!

Celebrating a new chapter at Kymos Group. After announcing the acquisition of Particle Analytical, our teams in Spain, Italy and Germany came together to celebrate these news and our CEO Joan Puig de Dou’s birthday. #KymosGroup #Acquisition #Team